Doctor profile · Federal record

Dr. David Petros, M.D.

Rheumatology Physician (CMS: Rheumatology) · Rheumatology Physician · Fayetteville, AR

  • NPI 1154306603
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 44 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1792 E Joyce Blvd
Fayetteville, AR 727035253
(479) 316-3003
fax (479) 316-3006
Mailing address
Po Box 497
Augusta, AR 720060497

Credentials & registration

NPPES · NUCC
NPI registered
December 2005 — 21 yrs on file
Profile last updated
June 26, 2025
Year of graduation
1982 — 44 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State licenses (2)
Arkansas #E-18451 · Texas #J0629

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1154306603. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
137,403
Distinct HCPCS
10
Medicare allowed
$2,690,435
HCPCS Description Services Patients Avg allowed
J3262 Injection, tocilizumab, 1 mg 75,640 18 $6
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 17,650 27 $41
J1602 Injection, golimumab, 1 mg, for intravenous use 15,150 20 $13
J0897 Injection, denosumab, 1 mg 10,320 108 $23
J1745 Injection, infliximab, excludes biosimilar, 10 mg 6,980 27 $33
J9312 Injection, rituximab, 10 mg 5,560 17 $80
99214 Established patient office or other outpatient visit, 30-39 minutes 2,238 847 $119
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 1,497 176 $1
96413 Administration of chemotherapy into vein, 1 hour or less 709 116 $121
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 257 120 $68

In context: peer comparison

Among 3 peers in Fayetteville Rheumatology Physician, average services per provider: 3,074. This provider delivers 45× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,461
Transactions
107
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen INC. 24 $644.75
Aurinia Pharma U.S., INC. 18 $313.52
Janssen Biotech, INC. 7 $249.58
GlaxoSmithKline, LLC. 7 $202.75
Abbvie INC. 13 $198.52
Pfizer INC. 7 $120.62
Radius Health, INC. 5 $113.64
AstraZeneca Pharmaceuticals Lp 5 $97.55
Ani Pharmaceuticals, INC. 4 $66.91
Lilly USA, LLC 4 $65.48
Fresenius Kabi USA, LLC 3 $64.09
Boehringer Ingelheim Pharmaceuticals, INC. 2 $60.97
Organon LLC 2 $57.88
Novartis Pharmaceuticals Corporation 3 $54.78
E.R. Squibb & Sons, L.L.C. 3 $54.11

By nature of payment

Food and Beverage
$2,361
Education
$100

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
3,117
Patients
634
Total drug cost
$669,388
Drug Type Claims Patients Total cost
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 821 105 $19,420
Prednisone Generic 614 150 $5,983
Methotrexate (Methotrexate Sodium) Brand 344 82 $11,907
Tramadol Hcl Generic 199 52 $1,257
Hydroxychloroquine Sulfate Generic 181 50 $7,416
Alendronate Sodium Generic 160 44 $1,244
Pregabalin Generic 116 15 $1,133
Celecoxib Generic 114 23 $2,198
Gabapentin Generic 98 26 $796
Allopurinol Generic 90 19 $1,378

Frequently asked questions

Auto-generated from federal data
What is Dr. David Petros's medical specialty?
Dr. David Petros practices Rheumatology Physician in Fayetteville, AR.
Where does Dr. David Petros practice?
Dr. David Petros practices at 1792 E Joyce Blvd, Fayetteville, AR 727035253. Office phone: 4793163003.
What is Dr. David Petros's NPI?
Dr. David Petros's National Provider Identifier (NPI) is 1154306603, issued by NPPES.
Does Dr. David Petros accept Medicare assignment?
Yes. Dr. David Petros accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David Petros commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.